OGEN
OGEN clinical trials: ORAGENICS INC
Every trial on ClinicalTrials.gov where ORAGENICS INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 3
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
OGEN on the catalyst calendar · OGEN registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jan 1, 2026Sponsor estimate | NCT06870240A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and...Oragenics, Inc. · Mild Traumatic Brain Injury, Concussion | OGENLead | Phase 2 | Not yet recruiting | Locked | Locked | Locked |
| Mar 31, 2020Actual | NCT03234465Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per DayOragenics, Inc. · Oral Mucositis | OGENLead | Phase 2 | Terminated | Locked | Locked | Locked |
| Aug 2012Sponsor estimate | NCT01520974Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)Oragenics, Inc. · Oral Health | OGENLead | No phase registered | Unknown status | Locked | Locked | Locked |
- Primary completion Jan 1, 2026Sponsor estimatePhase 2NCT06870240A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and...Oragenics, Inc. · Mild Traumatic Brain Injury, ConcussionNot yet recruitingOGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2020ActualPhase 2NCT03234465Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per DayOragenics, Inc. · Oral MucositisTerminatedOGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2012Sponsor estimateNo phase registeredNCT01520974Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)Oragenics, Inc. · Oral HealthUnknown statusOGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner